NASDAQ:IART

Integra Lifesciences Holdings Stock News

etoro logo Buy IART
*Your capital is at risk
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Several analysts have recently updated their ratings and price targets for Integra Lifesciences (NASDAQ: IART): 4/8/2020 – Integra Lifesciences had its price target lowered by analysts at BTIG Resea
The "Nerve Repair and Regeneration Market Report: Trends, Forecast, and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.
New York, April 14, 2020 -- Reportlinker.com announces the release of the report "Global Wound Dressing Market - Premium Insight, Competitive News Feed Analysis, Company.
Information on acquisition, funding, cap tables, investors, and executives for Integra (healthcare services). Use the PitchBook Platform to explore the full profile.
BTIG analyst Ryan Zimmerman maintained a Buy rating on Staar Surgical Company (STAA) today and set a price target of $41.00. The company's shares closed
BTIG analyst Ryan Zimmerman maintained a Buy rating on Staar Surgical Company (STAA – Research Report) today and set a
Norges Bank bought a new position in Integra Lifesciences Holdings Corp (NASDAQ:IART) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fu
Diversified Trust Co boosted its stake in shares of Integra Lifesciences Holdings Corp (NASDAQ:IART) by 10.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. T
Integra Lifesciences Holdings Corp (NASDAQ:IART) – Investment analysts at SunTrust Banks cut their Q2 2020 EPS estimates for shares of Integra Lifesciences in a report issued on Tuesday, April 7th.
Integra Lifesciences Holdings Corp (NASDAQ:IART) – Equities research analysts at SunTrust Banks lowered their Q1 2020 earnings per share estimates for Integra Lifesciences in a report released on Tu
Oppenheimer analyst Steven Lichtman maintained a Hold rating on Helius Medical Technologies (HSDT) today. The company's shares closed last Thursday at
Oppenheimer analyst Steven Lichtman maintained a Hold rating on Helius Medical Technologies ( HSDT – Research Report ) today. The company’s shares closed last Thursday at $0.26, close to its 52-we
The "Nerve Repair and Regeneration Market Report: Trends, Forecast, and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.
Investor confidence remains high in HealthEquity (HQY) stock, thanks to solid prospects.
Bio-Rad (BIO) launches a blood-based immunoassay kit to better detect antibodies in response to SARS-CoV-2 infection.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE